scholarly article | Q13442814 |
P50 | author | Kristen L Nowak | Q48040892 |
P2093 | author name string | Jessica Kendrick | |
Michel Chonchol | |||
Alfred K Cheung | |||
Anna J Jovanovich | |||
Christopher B Brady | |||
James D Kaufman | |||
P2860 | cites work | CKD associates with cognitive decline | Q33561710 |
Vitamin D and neurocognitive dysfunction: preventing "D"ecline? | Q33693884 | ||
Vitamin D and risk of cognitive decline in elderly persons | Q33742161 | ||
Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study | Q33782286 | ||
Calcium metabolism of brain in acute renal failure. Effects of uremia, hemodialysis, and parathyroid hormone | Q34461127 | ||
25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults | Q34485935 | ||
Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial | Q34582863 | ||
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study | Q34610179 | ||
FGF-23 and cognitive performance in hemodialysis patients | Q35647125 | ||
Cognitive function in dialysis patients | Q36064895 | ||
Association between serum 25(OH) vitamin D and the risk of cognitive decline in older women | Q36222215 | ||
Psychiatric and cognitive aspects of primary hyperparathyroidism | Q36667650 | ||
Low 25-hydroxyvitamin D levels and cognitive impairment in hemodialysis patients | Q36910962 | ||
Genes, endothelial function and cerebral small vessel disease in man. | Q36969770 | ||
Cognitive function in chronic kidney disease | Q37077771 | ||
Neuropsychological features in primary hyperparathyroidism: a prospective study | Q37212298 | ||
Detection of early dementia in the elderly | Q41170944 | ||
Impairment of spatial learning and memory in transgenic mice overexpressing human fibroblast growth factor-23. | Q42492760 | ||
FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease | Q42976674 | ||
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia | Q44414604 | ||
Biological variability of plasma intact and C-terminal FGF23 measurements | Q45399588 | ||
Endothelial dysfunction associated with mild cognitive impairment in elderly population. | Q45480945 | ||
Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly. | Q46549782 | ||
Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study | Q46797792 | ||
Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study | Q46800287 | ||
No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III. | Q46979586 | ||
Subclinical vascular disease of the brain in dialysis patients | Q48126601 | ||
The brain and the kidney connection: A model of accelerated vascular cognitive impairment | Q48481040 | ||
Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: a longitudinal pilot study | Q48495225 | ||
Role of uremia, brain calcium, and parathyroid hormone on changes in electroencephalogram in chronic renal failure | Q48673023 | ||
Cerebral small-vessel disease and decline in information processing speed, executive function and memory | Q48860735 | ||
Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. | Q50744694 | ||
Characteristics of two telephone screens for cognitive impairment. | Q51958962 | ||
Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. | Q53224110 | ||
Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients | Q61853240 | ||
Prevalence, recognition, and implications of mental impairment among hemodialysis patients | Q73491855 | ||
Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency | Q79485416 | ||
The cognition-kidney disease connection: lessons from population-based studies in the United States | Q81669064 | ||
Instability of fibroblast growth factor-23 (FGF-23): implications for clinical studies | Q83418512 | ||
P433 | issue | 5 | |
P921 | main subject | vitamin D | Q175621 |
veteran | Q193891 | ||
P304 | page(s) | S1-4 | |
P577 | publication date | 2014-11-01 | |
P1433 | published in | Clinical Nephrology | Q15763520 |
P1476 | title | 25-vitamin D, 1,25-vitamin D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD: a veteran population | |
P478 | volume | 82 |
Q98293278 | Association Between Chronic Kidney Disease-Mineral Bone Disease (CKD-MBD) and Cognition in Children: Chronic Kidney Disease in Children (CKiD) Study |
Q26748967 | Role of Vitamin D in Cognitive Function in Chronic Kidney Disease |
Q40281627 | Serum phosphate and cognitive function in older men. |
Q88868593 | The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review |
Q36182304 | Vitamin D, Fibroblast Growth Factor 23 and Incident Cognitive Impairment: Findings from the REGARDS Study. |
Search more.